Cargando…

Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax

Acute infection with Plasmodium vivax, classically associated with benign disease, has been presenting as serious and even fatal disease in recent years. Severe disease is mainly due to biochemical and hematological alterations during the acute phase of infection. In the present cross-sectional stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Guedes, Karla Sena, Sanchez, Bruno Antônio Marinho, Gomes, Luciano Teixeira, Fontes, Cor Jesus Fernandes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876935/
https://www.ncbi.nlm.nih.gov/pubmed/31765438
http://dx.doi.org/10.1371/journal.pone.0224877
_version_ 1783473291912019968
author Guedes, Karla Sena
Sanchez, Bruno Antônio Marinho
Gomes, Luciano Teixeira
Fontes, Cor Jesus Fernandes
author_facet Guedes, Karla Sena
Sanchez, Bruno Antônio Marinho
Gomes, Luciano Teixeira
Fontes, Cor Jesus Fernandes
author_sort Guedes, Karla Sena
collection PubMed
description Acute infection with Plasmodium vivax, classically associated with benign disease, has been presenting as serious and even fatal disease in recent years. Severe disease is mainly due to biochemical and hematological alterations during the acute phase of infection. In the present cross-sectional study, the aspartate aminotransferase-to-platelet ratio index (APRI) was evaluated as a method for identifying patients at risk of severe vivax malaria. This retrospective study included 130 patients with confirmed P. vivax infection between June 2006 and January 2018. Clinical-epidemiological data were obtained from medical records. Hematological and biochemical parameters were determined using automated equipment. The criteria of severity for infection by Plasmodium falciparum, established by the World Health Organization (WHO), were adapted to classify patients with danger signs of severe vivax malaria. Of the 130 patient’s records evaluated, 19 (14.6%) had one or more signs and symptoms of severe malaria. The mean APRI values among patients with and without severe malaria were 2.11 and 1.09, respectively (p = 0.044). Among those with severe disease, the proportion with an APRI value above 1.50 was 30% compared to the 10% among those without severe disease (p = 0.007). The area under the receiver operating characteristic curve (95% CI), calculated to assess the accuracy of the APRI in discriminating between patients with and without severe disease, was 0.645 (0.494; 0.795). An APRI cutoff of 0.74 resulted in sensitivity of 74.0%, specificity of 56.0%, and accuracy of 65.0%. This study shows that the APRI is elevated in patients with evidence of infection by P. vivax. Based on the good sensitivity found in this study, we conclude that this simple index can serve as a diagnostic biomarker to identify patients at risk of severe disease during the acute phase of P. vivax infection.
format Online
Article
Text
id pubmed-6876935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68769352019-12-08 Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax Guedes, Karla Sena Sanchez, Bruno Antônio Marinho Gomes, Luciano Teixeira Fontes, Cor Jesus Fernandes PLoS One Research Article Acute infection with Plasmodium vivax, classically associated with benign disease, has been presenting as serious and even fatal disease in recent years. Severe disease is mainly due to biochemical and hematological alterations during the acute phase of infection. In the present cross-sectional study, the aspartate aminotransferase-to-platelet ratio index (APRI) was evaluated as a method for identifying patients at risk of severe vivax malaria. This retrospective study included 130 patients with confirmed P. vivax infection between June 2006 and January 2018. Clinical-epidemiological data were obtained from medical records. Hematological and biochemical parameters were determined using automated equipment. The criteria of severity for infection by Plasmodium falciparum, established by the World Health Organization (WHO), were adapted to classify patients with danger signs of severe vivax malaria. Of the 130 patient’s records evaluated, 19 (14.6%) had one or more signs and symptoms of severe malaria. The mean APRI values among patients with and without severe malaria were 2.11 and 1.09, respectively (p = 0.044). Among those with severe disease, the proportion with an APRI value above 1.50 was 30% compared to the 10% among those without severe disease (p = 0.007). The area under the receiver operating characteristic curve (95% CI), calculated to assess the accuracy of the APRI in discriminating between patients with and without severe disease, was 0.645 (0.494; 0.795). An APRI cutoff of 0.74 resulted in sensitivity of 74.0%, specificity of 56.0%, and accuracy of 65.0%. This study shows that the APRI is elevated in patients with evidence of infection by P. vivax. Based on the good sensitivity found in this study, we conclude that this simple index can serve as a diagnostic biomarker to identify patients at risk of severe disease during the acute phase of P. vivax infection. Public Library of Science 2019-11-25 /pmc/articles/PMC6876935/ /pubmed/31765438 http://dx.doi.org/10.1371/journal.pone.0224877 Text en © 2019 Guedes et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Guedes, Karla Sena
Sanchez, Bruno Antônio Marinho
Gomes, Luciano Teixeira
Fontes, Cor Jesus Fernandes
Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
title Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
title_full Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
title_fullStr Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
title_full_unstemmed Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
title_short Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
title_sort aspartate aminotransferase-to-platelet ratio index (apri): a potential marker for diagnosis in patients at risk of severe malaria caused by plasmodium vivax
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876935/
https://www.ncbi.nlm.nih.gov/pubmed/31765438
http://dx.doi.org/10.1371/journal.pone.0224877
work_keys_str_mv AT guedeskarlasena aspartateaminotransferasetoplateletratioindexapriapotentialmarkerfordiagnosisinpatientsatriskofseveremalariacausedbyplasmodiumvivax
AT sanchezbrunoantoniomarinho aspartateaminotransferasetoplateletratioindexapriapotentialmarkerfordiagnosisinpatientsatriskofseveremalariacausedbyplasmodiumvivax
AT gomeslucianoteixeira aspartateaminotransferasetoplateletratioindexapriapotentialmarkerfordiagnosisinpatientsatriskofseveremalariacausedbyplasmodiumvivax
AT fontescorjesusfernandes aspartateaminotransferasetoplateletratioindexapriapotentialmarkerfordiagnosisinpatientsatriskofseveremalariacausedbyplasmodiumvivax